BioSpace News Archive

Pivotal today announced that it has been contracted by Lucid Diagnostics Inc., a New York City-based company subsidiary of PAVmed (NASDAQ: PAVM), to provide expert clinical research services for its upcoming clinical studies of its GI in-vitro diagnostics EsoGuard™ and EsoCheck™ in the U.S. and Europe.

Pulse Biosciences, Inc., a novel bioelectric medicine company, announced an update on its U.S. Food and Drug Administration submission for the CellFX System.

ESSA Pharma Inc., a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal first quarter ended December 31, 2019.

Dr. Derya Tilki, attending urologist at the Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, presented the results of the recently completed Case-Control validation study of 1,436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of 600 patients.

It is not uncommon for children and teens with autism spectrum disorder to struggle with sleep.

Deciphera Pharmaceuticals, Inc. announced the pricing of its previously announced registered underwritten public offering of 3,181,818 shares of its common stock at a price to the public of $55.00 per share.

Bio-Rad Laboratories, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.